237 related articles for article (PubMed ID: 38475849)
21. Estimating national, regional and provincial cost-effectiveness of introducing childhood 13-valent pneumococcal conjugate vaccination in China: a modelling analysis.
Lai X; Garcia C; Wu D; Knoll MD; Zhang H; Xu T; Jing R; Yin Z; Wahl B; Fang H
Lancet Reg Health West Pac; 2023 Mar; 32():100666. PubMed ID: 36785861
[TBL] [Abstract][Full Text] [Related]
22. A review of rotavirus vaccine use in Asia and the Pacific regions: challenges and future prospects.
Buchy P; Chen J; Zhang XH; Benninghoff B; Lee C; Bibera GL
Expert Rev Vaccines; 2021 Dec; 20(12):1499-1514. PubMed ID: 33275065
[TBL] [Abstract][Full Text] [Related]
23. Increasing immunization coverage.
Hammer LD; Curry ES; Harlor AD; Laughlin JJ; Leeds AJ; Lessin HR; Rodgers CT; Granado-Villar DC; Brown JM; Cotton WH; Gaines BM; Gambon TB; Gitterman BA; Gorski PA; Kraft CA; Marino RV; Paz-Soldan GJ; Zind B; ;
Pediatrics; 2010 Jun; 125(6):1295-304. PubMed ID: 20513736
[TBL] [Abstract][Full Text] [Related]
24. Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries.
Guillaume D; Waheed DE; Schleiff M; Muralidharan KK; Vorsters A; Limaye RJ
PLoS One; 2024; 19(1):e0291990. PubMed ID: 38227567
[TBL] [Abstract][Full Text] [Related]
25. How to address vaccine hesitancy? Lessons from National Hepatitis B Immunization Program in China.
Jiang H; Wei C
Front Public Health; 2024; 12():1286801. PubMed ID: 38317799
[TBL] [Abstract][Full Text] [Related]
26. Vaccine events raising public concern and associated immunization program policy and practice changes, China, 2005-2021.
Liu X; Yu W; Yin Z; Rodewald L; Song Y; Zhang Z; Ye J; Li L; Cao L; Cao L
Vaccine; 2022 Apr; 40(18):2561-2567. PubMed ID: 35339307
[TBL] [Abstract][Full Text] [Related]
27. Using big data to analyze the vaccination status of children with congenital heart disease in Yinzhou District, China.
Zhang L; Yang Z; Yin Y; Huang W; Yi T; Ping J; Liu L; Shen P; Sun Y; Lin H
Hum Vaccin Immunother; 2024 Dec; 20(1):2319967. PubMed ID: 38465660
[TBL] [Abstract][Full Text] [Related]
28. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
[TBL] [Abstract][Full Text] [Related]
29. The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization.
Kane MA; Hadler SC; Lee L; Shapiro CN; Cui F; Wang X; Kumar R
Vaccine; 2013 Dec; 31 Suppl 9():J15-20. PubMed ID: 24331015
[TBL] [Abstract][Full Text] [Related]
30. Utilization pattern of Haemophilus influenza type b vaccine in eight provinces of China.
Li Y; Yue C; Wang Y; Zhu X; Martin K; Scherpbier RW; Liu J; Wang Z; Ma Y; Cheng H; Zhang Z; Wang Q; Li H; Xie S; Xiao Q; Wang H; An Z
Hum Vaccin Immunother; 2018 Apr; 14(4):894-899. PubMed ID: 29300680
[TBL] [Abstract][Full Text] [Related]
31. TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination.
Clark A; Jauregui B; Griffiths U; Janusz CB; Bolaños-Sierra B; Hajjeh R; Andrus JK; Sanderson C
Vaccine; 2013 Jul; 31 Suppl 3():C19-29. PubMed ID: 23777686
[TBL] [Abstract][Full Text] [Related]
32. Status of New Vaccine Introduction - Worldwide, September 2016.
Loharikar A; Dumolard L; Chu S; Hyde T; Goodman T; Mantel C
MMWR Morb Mortal Wkly Rep; 2016 Oct; 65(41):1136-1140. PubMed ID: 27764083
[TBL] [Abstract][Full Text] [Related]
33. Vaccine-preventable disease control in the People's Republic of China: 1949-2016.
Yu W; Lee LA; Liu Y; Scherpbier RW; Wen N; Zhang G; Zhu X; Ning G; Wang F; Li Y; Hao L; Zhang X; Wang H
Vaccine; 2018 Dec; 36(52):8131-8137. PubMed ID: 30497834
[TBL] [Abstract][Full Text] [Related]
34. Successful introduction of an underutilized elderly pneumococcal vaccine in a national immunization program by integrating the pre-existing public health infrastructure.
Yang TU; Kim E; Park YJ; Kim D; Kwon YH; Shin JK; Park O
Vaccine; 2016 Mar; 34(13):1623-1629. PubMed ID: 26850759
[TBL] [Abstract][Full Text] [Related]
35. Promoting immunization equity in Latin America and the Caribbean: Case studies, lessons learned, and their implication for COVID-19 vaccine equity.
Chan IL; Mowson R; Alonso JP; Roberti J; Contreras M; Velandia-González M
Vaccine; 2022 Mar; 40(13):1977-1986. PubMed ID: 35221122
[TBL] [Abstract][Full Text] [Related]
36. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
Menzies R; Turnour C; Chiu C; McIntyre P
Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
[TBL] [Abstract][Full Text] [Related]
37. Invasive bacterial diseases: national surveillance in Italy and vaccination coverage in the Local Health Agency 4 "Chiavarese", Liguria region (Italy).
Trucchi C; Zoppi G
J Prev Med Hyg; 2012 Jun; 53(2):120-4. PubMed ID: 23240174
[TBL] [Abstract][Full Text] [Related]
38. Global Routine Vaccination Coverage, 2015.
Casey RM; Dumolard L; Danovaro-Holliday MC; Gacic-Dobo M; Diallo MS; Hampton LM; Wallace AS
MMWR Morb Mortal Wkly Rep; 2016 Nov; 65(45):1270-1273. PubMed ID: 27855146
[TBL] [Abstract][Full Text] [Related]
39. The landscape of vaccines in China: history, classification, supply, and price.
Zheng Y; Rodewald L; Yang J; Qin Y; Pang M; Feng L; Yu H
BMC Infect Dis; 2018 Oct; 18(1):502. PubMed ID: 30286735
[TBL] [Abstract][Full Text] [Related]
40.
Slack M; Esposito S; Haas H; Mihalyi A; Nissen M; Mukherjee P; Harrington L
Expert Rev Vaccines; 2020 Oct; 19(10):903-917. PubMed ID: 32962476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
